Use of upper endoscopy to evaluate patients with a positive faecal occult blood test and negative colonoscopy: Is it appropriate?

Digestive and Liver Disease

Volumn 38, Issue 7, 2006, Pages 507-510

  Bini, E J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ARTICLE; BARRETT ESOPHAGUS; CANCER SCREENING; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM CANCER; DUODENUM CANCER; DUODENUM TUMOR; DUODENUM ULCER; EROSIVE GASTRITIS; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS STRICTURE; FREQUENCY ANALYSIS; HUMAN; OCCULT BLOOD TEST; PREDICTION; SENSITIVITY AND SPECIFICITY; STOMACH POLYP; STOMACH ULCER; UPPER GASTROINTESTINAL TRACT;

EID: 33748507091     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.02.017     Document Type: Note

References (31)

1. Pignone M., Saha S., Hoerger T., and Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 96-104
2. Mandel J.S., Church T.R., Bond J.H., Ederer F., Geisser M.S., Mongin S.J., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
3. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328 (1993) 1365-1371
4. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., and Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996) 1467-1471
5. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
6. Pignone M., Rich M., Teutsch S.M., Berg A.O., and Lohr K.N. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 132-141
7. Smith R.A., Cokkinides V., and Eyre H.J. American cancer society guidelines for the early detection of cancer, 2005. CA Cancer J Clin 55 (2005) 31-44
8. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
9. Rex D.K., Johnson D.A., Lieberman D.A., Burt R.W., and Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 95 (2000) 868-877
10. American Society for Gastrointestinal Endoscopy. Guidelines for colorectal cancer screening and surveillance. Gastrointest Endosc 51 (2000) 777-782
11. Ransohoff D.F., and Lang C.A. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med 126 (1997) 811-822
12. Allison J.E. Review article: faecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther 12 (1998) 1-10
13. Sharma V.K., Corder F.A., Fancher J., and Howden C.W. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am J Gastroenterol 95 (2000) 3629-3632
14. Nadel M.R., Shapiro J.A., Klabunde C.N., Seeff L.C., Uhler R., Smith R.A., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 142 (2005) 86-94
15. Young G.P., St John D.J., Winawer S.J., and Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97 (2002) 2499-2507
16. Hisamuddin K., Mowat N.A.G., and Phull P.S. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients. Dig Liver Dis 38 (2006) 503-507
17. Zuckerman G., and Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol 87 (1992) 62-66
18. Hsia P.C., and Al Kawas F.H. Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol 87 (1992) 1571-1574
19. Geller A.J., Kolts B.E., Achem S.R., and Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol 88 (1993) 1184-1187
20. Chen Y.K., Gladden D.R., Kestenbaum D.J., and Collen M.J. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy?. Am J Gastroenterol 88 (1993) 2026-2029
21. Rockey D.C., Koch J., Cello J.P., Sanders L.L., and McQuaid K. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med 339 (1998) 153-159
22. Bini E.J., Rajapaksa R.C., Valdes M.T., and Weinshel E.H. Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy?. Am J Med 106 (1999) 613-618
23. Velez J.P., Schwesinger W.H., Stauffer J., Gaskill III H.V., Kazantsev G.B., Sirinek K.R., et al. Bidirectional endoscopy in patients with fecal occult blood. Surg Endosc 16 (2002) 117-120
24. Ali M., Yaqub M., Haider Z., Anees I., Bhargava S., and Gian J. Yield of dual endoscopy for positive fecal occult blood test. Am J Gastroenterol 98 (2003) 82-85
25. Bini E.J., Rajapaksa R.C., and Weinshel E.H. Positive predictive value of fecal occult blood testing in persons taking warfarin. Am J Gastroenterol 100 (2005) 1586-1592
26. Thomas W.M., and Hardcastle J.D. Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. Gut 31 (1990) 1294-1297
27. Rasmussen M., and Kronborg O. Upper gastrointestinal cancer in a population-based screening program with fecal occult blood test for colorectal cancer. Scand J Gastroenterol 37 (2002) 95-98
28. Ahlquist D.A., Wieand H.S., Moertel C.G., McGill D.B., Loprinzi C.L., O'Connell M.J., et al. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. J Am Med Assoc 269 (1993) 1262-1267
29. Allison J.E., Tekawa I.S., Ransom L.J., and Adrain A.L. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334 (1996) 155-159
30. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Turnbull B.A., and Ross M.E. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351 (2004) 2704-2714
31. Song K., Fendrick A.M., and Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 126 (2004) 1270-1279